Table 1.
7-Day NIHSS ≤ 6 (n = 28) |
7-Day NIHSS > 6 (n = 42) |
p-Value | n Missing | |
---|---|---|---|---|
Female, n (%) | 20 (71.4) | 21 (50.0) | 0.0882 | 0 |
Age, years (mean ± SD) | 72 ± 11 | 73 ± 10 | 0.5933 | 0 |
Time from last seen well to punction, min (median [Q1–Q3]) | 160 [185–250] | 189 [220–330] | 0.2056 | 3 |
Narrowest segment of AComA/cA1 complex, mm (mean ± SD) | 1.56 ± 0.63; | 1.13 ± 0.58; | 0.0043 | 0 |
ASPECT score on admission, points (median [Q1–Q3]) | 8 [9–10] | 7 [9–10] | 0.3150 | 0 |
NIHSS score on admission, points (median [Q1–Q3]) | 17.5 [15.5–21.5] | 19 [14–21] | 0.8177 | 0 |
Intravenous recombinant tissue plasminogen activator, n (%) | 15 (53.6) | 17 (40.5) | 0.3324 | 0 |
Primary arterial hypertension, n (%) | 7 (25.0) | 12 (28.6) | 0.7152 | 36 |
Heart failure, n (%) | 4 (14.3) | 8 (19.0) | 1.0000 | 36 |
Diabetes mellitus, n (%) | 2 (7.1) | 2 (4.8) | 0.5672 | 37 |
Hemorrhage on follow-up CT, n (%) | 2 (7.1) | 12 (28.6) | 0.0674 | 37 |
Seven-day mortality, n (%) | 6 (8.6) | |||
Hemorrhagic transformation of stroke PH2, n (%) | 5 (7.1) |